Description

Buy Fiasp Insulin online, Fiasp insulin for sale

Buy Fiasp Insulin, Fiasp Insulin  (insulin aspart injection) 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.

Novo Nordisk pharmaceutical company received European Commission (EMA) approval to market the new fast-acting insulin brand Fiasp in 28 European Union countries, as well as Norway and Iceland. On March 27, 2017, the drug began to enter the Canadian market.

Prandial, that is, introduced to compensate for carbohydrates from food, “accelerated” insulin Fiasp is a modified, well-known to everyone, insulin Aspart (Novorapid). Two components have been added to the innovative formulation:

Vitamin B3 (niacinamide) to increase the rate of insulin absorption;
Amino acid L-Arginine for drug stability.
On Insulinguru.com you can find the following variations of the medication:

Insulin Fiasp Vial 10 ml 100iu/ml;
Insulin Fiasp Flextouch 5×3.0ml 100iu/ml;
Insulin Fiasp Cartridge 5×3.0 ml 100iu/ml.
To buy these or any other insulin products from our company, you will need to attach a valid prescription for the drug from the doctor. Without the prescription, our specialists will have to decline your order.

Place an order to Buy Insulin Online

we have a wide assortment of high-quality insulin products and their analogs. Moreover, it offers a beneficial pricing system and quick worldwide shipping. So, buy insulin online in an advantageous way!

What kind of insulin is Fiasp? 

Insulin Aspart that comprises the base for Fiasp insulin is a fast-acting human analog insulin. In the molecular structure of this insulin, the amino acid proline in position B28 is replaced by aspartic acid, which reduces the tendency of molecules to form hexamers, which is observed in ordinary insulin solutions.

The hypoglycemic effect is associated with an increase in intracellular transport and an increase in glucose uptake by tissues, stimulation of lipogenesis, gluconeogenesis, and a decrease in the rate of glucose production by the liver.

The goal of Fiasp insulin was to achieve faster onset of action and improved postprandial glycemic control.

How long does it take for Fiasp to start working and lower blood sugar?

The efficacy and safety profile of Fiasp was studied in a clinical trial program consisting of four studies covering more than 2,100 people with type 1 and type 2 diabetes. The results of three studies carried out in patients with type 1 diabetes mellitus showed that the effect of insulin begins to unfold 5 minutes earlier and reaches a peak 11 minutes faster when using insulin Fiasp compared to Novorapid. The duration of action of the new insulin was shorter, and the residual glucose-lowering effect was 10% less pronounced than that of Novorapid insulin.